<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">WJCD</journal-id><journal-title-group><journal-title>World Journal of Cardiovascular Diseases</journal-title></journal-title-group><issn pub-type="epub">2164-5329</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/wjcd.2019.91005</article-id><article-id pub-id-type="publisher-id">WJCD-90235</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  Prognostic Factors for Acute Heart Failure (AHF) in the Cardiology Intensive Care Unit (ICU) of the University Hospital Point G (UH Pt G)
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Camara</surname><given-names>Youssouf</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Ba</surname><given-names>Hamidou Oumar</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Sangare</surname><given-names>Ibrahima</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Toure</surname><given-names>Karamba</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Coulibaly</surname><given-names>Souleymane</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Sacko</surname><given-names>Abdoul Karim</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Coulibaly</surname><given-names>Alfousseyni</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Diallo</surname><given-names>Nouhoum</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Sidibe</surname><given-names>Samba</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Daou</surname><given-names>Adama</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Menta</surname><given-names>Ichaka</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Diall</surname><given-names>Ilo Bella</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Diallo</surname><given-names>Boubakar Abdoulaye</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib></contrib-group><aff id="aff3"><addr-line>University Hospital Point G, Bamako, Mali</addr-line></aff><aff id="aff2"><addr-line>University Hospital Gabriel Touré, Bamako, Mali</addr-line></aff><aff id="aff4"><addr-line>Disease Fighting Centers, Bamako, Mali</addr-line></aff><aff id="aff1"><addr-line>University Hospital Sidy Bocar Sall, Kati, Mali</addr-line></aff><pub-date pub-type="epub"><day>10</day><month>01</month><year>2019</year></pub-date><volume>09</volume><issue>01</issue><fpage>42</fpage><lpage>50</lpage><history><date date-type="received"><day>2,</day>	<month>January</month>	<year>2019</year></date><date date-type="rev-recd"><day>25,</day>	<month>January</month>	<year>2019</year>	</date><date date-type="accepted"><day>28,</day>	<month>January</month>	<year>2019</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Background and Aim:
   The absence of data in our context motivates this study aiming to determine the frequency of AHF at the ICU, assess the in-hospital evolution of the disease and to find out poor prognosis.<b>Material and Methods:</b> It was an observational and descriptive study covering the time from January 1, 2014 to March 30, 2017 involving all inpatient records in ICU
  .
   From January 2014 to December 2017, collected data included those on socio-demographic, history of diseases
   and
   physical examination, 
  and 
  some labor dat
  a
  including Pro BNP, serum creatinine, blood ionogram, cardiac enzymes
   and
   blood count. Also data electrocardiography,
   echocardiography and in-hospital evolution were collected. <b>Statistical Analysis:</b>Statistical analysis was performed using SPSS (IBM Inc) version 18. 
  <b style="line-height:1.5;">Results: </b>
  AHF occured in 47.36% with a mean age of 58.74 &#177; 18.407 and extremes of 17 and 90 years, women representing 53.1% (sex ratio Male:Female = 0.88). Hypertension and diabetes were the predominant cardiovascular risk factors with respectively 67.4% and 18.4%. At admission 44%, 37.7% and 17.9% of patients were respectively hypertensive, normotensive and hypotensive. The clinical expression was mainly global heart failure with 42.6% followed by left heart failure and right heart failure with respectively 37% and 20.4%. The coronary syndromes (all forms) was the first cause of ICA with 34% of cases followed by pulmonary embolism and hypertension with respectively 25.3% and 24.1%. Mean hospital stay was 5.61 &#177; 3.527 days (1 to 25 days). Complications were recorded in 18.5% of patients with cardiogenic shock in
   
  half of all cases. In multi-variate analysis, only hypotension at admission was shown to be the independent factor of poor prognosis with p = 0.016 and OR = 4.453 (1.322 - 14.996). 
  <b style="line-height:1.5;">Conclusion: </b>
  As a common manifestation heart failure can be rapidly fatal in presence of collapsus or hypotension at admission. These factors should be accurately managed to reduce mortality, which remains high in our context.
 
</p></abstract><kwd-group><kwd>Acute Heart Failure</kwd><kwd> Prognostic Factors</kwd><kwd> Cardiology</kwd><kwd> Intensive Care Unit</kwd><kwd> Bamako</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Acute heart failure (AHF) refers to the rapid onset or worsening of symptoms or signs of heart failure [<xref ref-type="bibr" rid="scirp.90235-ref1">1</xref>] . It represents more than 20 million hospitalizations worldwide [<xref ref-type="bibr" rid="scirp.90235-ref2">2</xref>] and can be either “de novo” or most often due to the acute decompensation of chronic heart failure [<xref ref-type="bibr" rid="scirp.90235-ref1">1</xref>] . Heart failure can be classified in different ways, left or right sided, with altered or preserved ejection fraction, acute or chronic.</p><p>AHF accounts for 1 million hospitalizations in the United States [<xref ref-type="bibr" rid="scirp.90235-ref2">2</xref>] , 1876 hospitalizations in a study in Japan [<xref ref-type="bibr" rid="scirp.90235-ref3">3</xref>] and 67,000 hospitalizations in Great Britain and Wales [<xref ref-type="bibr" rid="scirp.90235-ref4">4</xref>] .</p><p>AHF also causes high morbidity and mortality. In-hospital mortality in Europe is estimated between 4% and 7% [<xref ref-type="bibr" rid="scirp.90235-ref5">5</xref>] , 45% and 13% for 95th percentile respectively in Senegal and Nigeria in 2001 [<xref ref-type="bibr" rid="scirp.90235-ref6">6</xref>] and the average survival rate at 5 years is 50% [<xref ref-type="bibr" rid="scirp.90235-ref4">4</xref>] .</p><p>There is an absence of published data in our context, motivating this study which aims to determine the frequency of AHF at the ICU, assess the in-hospital evolution of the disease and find out which factors lead to poor prognosis.</p></sec><sec id="s2"><title>2. Material and Methods</title><p>It was an observational and descriptive study covering the time from January 01, 2014 to March 30, 2017 involving all inpatient records in ICU. The sampling was exhaustive, including all patients admitted for AHF in the ICU oft he UH Pt G and excluding those admitted in ICU for others conditions.</p><p>Collected data included those on:</p><p>- socio-demographic characteristics: age, sex, occupation, residence.</p><p>- past medical history and cardiovascular risk factors.</p><p>- history of the disease: onset of symptoms, functional signs (dyspnea stage III or IV NYHA, chest pain).</p><p>- physical examination: measures of blood pressure, search for clinical signs of heart failure (left, right).</p><p>- labor data: Pro BNP, serum creatinine, blood ionogram, cardiac enzymes, blood cell count.</p><p>- electrocardiography: presence of atrial fibrillation, high-grade atrioventricular block, signs of myocardial ischemia.</p><p>- echocardiography: measurement of chambers size, evaluation of wall motion, systolic function of both left and right ventricles, significant valvular diseases (at least grade III), evaluation of filling pressures of the Left ventricle, pulmonary arterial pressure, evaluation of pericardial effusion.</p><p>- chest computer tomogramm in cases of pulmonary embolism suspicion for occlusion of the pulmonary artery.</p><p>- in-hospital evolution.</p><p>These data were collected on an anonymous survey formulary and then inserted into an EPI INFO 7 (CDC Atlanta) database.</p><p>Ethical Consideration: confidentiality rules were respected throughout the study.</p><p>Statistical Analysis was performed using SPSS (IBM Inc) version 18. The chi-square and Fisher-tests for small numbers were the tests used for statistical analysis.</p></sec><sec id="s3"><title>3. Results</title>Description of the Sample<p>During the study period 162 patients of 342 were admitted for AHF (47.36%) with an average age of 58.74 &#177; 18.407 ranging from 17 to 90 years. The modal class was 50 - 75 years with 51.23% (<xref ref-type="table" rid="table1">Table 1</xref>). A proportion of 76 men for 86 women constituted the sample, giving a sex ratio Male: Female of 0.88 (<xref ref-type="table" rid="table1">Table 1</xref>).</p><p>Heart failure was found in the past medical history in 16.7% and hypertenion was the most frequent cardiovascularrisk factor with 67.4%, followed by diabetes (18.4%) (<xref ref-type="table" rid="table2">Table 2</xref>).</p><p>Patients had hypotension at admission in 17.9%, hypertension in 44.4% and normal blood pressure in 37.7% of cases.</p><p>According to the location, global heart failure (GHF) (left + right sided) was the most frequent form with 42.6% followed by left heart failure (LHF) in 37% of cases and right heart failure (RHF) in 20.4% of patients (Diagram 1).</p><p>In echocardiography LVEF was normal in 43% and severely reduced in 24% of all cases (Diagram 2).</p><p>Acute coronary syndrome (ACS) was the leading cause of AHF with 34% of all cases followed by pulmonary embolism and hypertension with respectively 25.3% and 24.1% (<xref ref-type="table" rid="table3">Table 3</xref>).</p><p>Mean hospital stay was 5.61 &#177; 3.527 days ranging from 1 to 25 days. A proportion of 36.6% stayed more than 7 days.</p><p>Cardiogenic shock was the most common complication (9.25%) followed by electrolyte disorders (<xref ref-type="table" rid="table4">Table 4</xref>).</p><p>Mortality and factors of poor prognosis:</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Socio-demographic data in the sample of 162 patients admitted for AHF in the ICU of the UH Pt G</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  colspan="2"  >Characters</th><th align="center" valign="middle" >Number</th><th align="center" valign="middle" >%</th></tr></thead><tr><td align="center" valign="middle"  rowspan="3"  >Age group (years)</td><td align="center" valign="middle" >&lt;50</td><td align="center" valign="middle" >48</td><td align="center" valign="middle" >29.62</td></tr><tr><td align="center" valign="middle" >50 - 75</td><td align="center" valign="middle" >83</td><td align="center" valign="middle" >51.23</td></tr><tr><td align="center" valign="middle" >&gt;75</td><td align="center" valign="middle" >31</td><td align="center" valign="middle" >19.13</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Sex</td><td align="center" valign="middle" >Male</td><td align="center" valign="middle" >76</td><td align="center" valign="middle" >46.9</td></tr><tr><td align="center" valign="middle" >Female</td><td align="center" valign="middle" >86</td><td align="center" valign="middle" >53.1</td></tr></tbody></table></table-wrap><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Medical history and cardiovascular risk factors in the sample of 162 patients admitted for AHF in the ICU of the UH Pt G</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Medical history/cardiovascular risk factors</th><th align="center" valign="middle" >Number</th><th align="center" valign="middle" >%</th></tr></thead><tr><td align="center" valign="middle" >Heart failure</td><td align="center" valign="middle" >27</td><td align="center" valign="middle" >16.7</td></tr><tr><td align="center" valign="middle" >Hypertension</td><td align="center" valign="middle" >95</td><td align="center" valign="middle" >67.4</td></tr><tr><td align="center" valign="middle" >Diabetes</td><td align="center" valign="middle" >26</td><td align="center" valign="middle" >18.4</td></tr><tr><td align="center" valign="middle" >Tobacco smoking</td><td align="center" valign="middle" >16</td><td align="center" valign="middle" >11.4</td></tr><tr><td align="center" valign="middle" >Dyslipidemia</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >2.8</td></tr></tbody></table></table-wrap><table-wrap id="table3" ><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> Distribtion of etiologies in the sample of 162 patients admitted for AHF in the ICU of the UH Pt G</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Etiologies</th><th align="center" valign="middle" >Number</th><th align="center" valign="middle" >%</th></tr></thead><tr><td align="center" valign="middle" >Acute coronary syndrom</td><td align="center" valign="middle" >55</td><td align="center" valign="middle" >34</td></tr><tr><td align="center" valign="middle" >Pulmonary embolism</td><td align="center" valign="middle" >41</td><td align="center" valign="middle" >25.3</td></tr><tr><td align="center" valign="middle" >Hypertension</td><td align="center" valign="middle" >39</td><td align="center" valign="middle" >24.1</td></tr><tr><td align="center" valign="middle" >Cardiomyopathy</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >4.9</td></tr><tr><td align="center" valign="middle" >Heart rhythm disorders</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >4.9</td></tr><tr><td align="center" valign="middle" >Decompensated or pulmonale chronicum</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >3.1</td></tr><tr><td align="center" valign="middle" >Conduction disorders</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >1.9</td></tr><tr><td align="center" valign="middle" >Valvular heart diseases</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >1.2</td></tr><tr><td align="center" valign="middle" >Pericardial effusion (tamponnade)</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0.6</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >162</td><td align="center" valign="middle" >100</td></tr></tbody></table></table-wrap><table-wrap id="table4" ><label><xref ref-type="table" rid="table4">Table 4</xref></label><caption><title> In-hospital evolution in the sample of 162 patients admitted for AHF in the ICU of the UH Pt G</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Event</th><th align="center" valign="middle" >Number</th><th align="center" valign="middle" >%</th></tr></thead><tr><td align="center" valign="middle" >Cardiogenic schock</td><td align="center" valign="middle" >15</td><td align="center" valign="middle" >9.25</td></tr><tr><td align="center" valign="middle" >Serum electrolyt disorders</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >3.08</td></tr><tr><td align="center" valign="middle" >Atrial fibrillation</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >1.23</td></tr><tr><td align="center" valign="middle" >Abortion</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >1.23</td></tr><tr><td align="center" valign="middle" >Others</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >0.61</td></tr><tr><td align="center" valign="middle" >Death</td><td align="center" valign="middle" >52</td><td align="center" valign="middle" >32.09</td></tr></tbody></table></table-wrap><disp-formula id="scirp.90235-formula1"><graphic  xlink:href="//html.scirp.org/file/5-1910818x2.png"  xlink:type="simple"/></disp-formula><p>Diagram 1. Type of heart failure in the sample of 162 patients admitted for AHF in the ICU of the UH Pt G.</p><disp-formula id="scirp.90235-formula2"><graphic  xlink:href="//html.scirp.org/file/5-1910818x3.png"  xlink:type="simple"/></disp-formula><p>Diagram 2. R&#233;partition of left ventricular fonction at admission in the sample of 79 patients admitted for AHF in the ICU of the UH Pt G.</p><p>Overall in-hospital mortality was 32.09%. Female mortality appeared to be higher than that of men (33.7% versus 30.3% ) but without statistical difference, p = 0.63. Patients over 75 years and under 50 years had the highest in-hospital mortality rate but without any statistical difference, p = 0.70 (<xref ref-type="table" rid="table5">Table 5</xref>).</p><p>Having a history of heart failure was statistically (p = 0.02) associated with high mortality with 51.9% specific mortality. The GHF mortality (39.1%) was statistically higher than that of RHF (p = 0.01) and also higher than that of LHF (p = 0.03). Mortality due to the presence of arterial hypotension or cardiogenic shock (67.85%) at admission was statistically higher compared with normal or elevated blood pressure, p &lt; 0.0001. The existence of a severely impaired left ventricular ejection fraction was a poor prognostic factor with a mortality of 63.2%; p = 0.002 (<xref ref-type="table" rid="table5">Table 5</xref>).</p><p>The most fatal complication was cardiogenic shock with a specific mortality of 93.33%, p = 0.008.</p><p>ACS was the most fatal etiology with 38.46% (p = 0.12) (<xref ref-type="table" rid="table5">Table 5</xref>).</p><p>In logistic regression, only a state of collapse or arterial hypotension at admission was found to be the independent poor prognostic factor with p = 0.016 and OR = 4.453 (1.322 - 14.996) (<xref ref-type="table" rid="table6">Table 6</xref>).</p><p>The level of the systolic ejection fraction could not be analyzed in logistic regression because of the low proportion (48.8%) of patients who received echocardiography.</p><table-wrap id="table5" ><label><xref ref-type="table" rid="table5">Table 5</xref></label><caption><title> Distribution of mortality according to various pronostic factors in the sample of 162 patients admitted for AHF in the ICU of the UH Pt G</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  colspan="2"  >Factors</th><th align="center" valign="middle" >Number of deaths (%)</th><th align="center" valign="middle" >p</th></tr></thead><tr><td align="center" valign="middle"  rowspan="2"  >Sex</td><td align="center" valign="middle" >Male</td><td align="center" valign="middle" >23 (30.3)</td><td align="center" valign="middle"  rowspan="2"  ></td></tr><tr><td align="center" valign="middle" >Female</td><td align="center" valign="middle" >29 (33.7)</td></tr><tr><td align="center" valign="middle"  rowspan="3"  >Age group (years)</td><td align="center" valign="middle" >&lt;50</td><td align="center" valign="middle" >17 (35.4)</td><td align="center" valign="middle"  rowspan="3"  >0.70</td></tr><tr><td align="center" valign="middle" >50 - 75</td><td align="center" valign="middle" >24 (28.9)</td></tr><tr><td align="center" valign="middle" >&gt;75</td><td align="center" valign="middle" >11 (35.5)</td></tr><tr><td align="center" valign="middle"  colspan="2"  >Medical history of heart failure</td><td align="center" valign="middle" >14 (51.9)</td><td align="center" valign="middle" >0.02</td></tr><tr><td align="center" valign="middle"  rowspan="3"  >Blood pressure at admission</td><td align="center" valign="middle" >Hypertension</td><td align="center" valign="middle" >17 (23.6)</td><td align="center" valign="middle"  rowspan="3"  >&lt;0.0001</td></tr><tr><td align="center" valign="middle" >Normotension</td><td align="center" valign="middle" >16 (25.8)</td></tr><tr><td align="center" valign="middle" >Hypotension/collapse</td><td align="center" valign="middle" >19 (67.9)</td></tr><tr><td align="center" valign="middle"  rowspan="3"  >Type of heart failure</td><td align="center" valign="middle" >GHF</td><td align="center" valign="middle" >27 (39.1)</td><td align="center" valign="middle"  rowspan="3"  >0.03</td></tr><tr><td align="center" valign="middle" >LHF</td><td align="center" valign="middle" >21 (35.0)</td></tr><tr><td align="center" valign="middle" >RHF</td><td align="center" valign="middle" >4 (12.1)</td></tr><tr><td align="center" valign="middle" >Left ventricular fonction</td><td align="center" valign="middle" >Normal</td><td align="center" valign="middle" >7 (20.6)</td><td align="center" valign="middle"  rowspan="4"  >0.02</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >Lightly reduced</td><td align="center" valign="middle" >2 (20.0)</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >Moderately reduced</td><td align="center" valign="middle" >2 (12.5)</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >Severely reduced</td><td align="center" valign="middle" >12 (63.2)</td></tr><tr><td align="center" valign="middle"  rowspan="2"  >Complications</td><td align="center" valign="middle" >cardiogenic schock</td><td align="center" valign="middle" >14 (93.3)</td><td align="center" valign="middle"  rowspan="2"  >p = 0.008</td></tr><tr><td align="center" valign="middle" >Serum electrolyt disorders</td><td align="center" valign="middle" >4 (80)</td></tr><tr><td align="center" valign="middle" >Etiology</td><td align="center" valign="middle" >ACS</td><td align="center" valign="middle" >20 (36.4)</td><td align="center" valign="middle" >0.12</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >Pulmonary embolism</td><td align="center" valign="middle" >9 (22.0)</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >Hypertension</td><td align="center" valign="middle" >10 (25.6)</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >Cardiomyopathie</td><td align="center" valign="middle" >5 (62.5)</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >Heart rhythm disorders</td><td align="center" valign="middle" >5 (62.5)</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >Cor pulmonale chronicum</td><td align="center" valign="middle" >2 (40.0)</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Hospital stay (days)</td><td align="center" valign="middle" >&lt;7</td><td align="center" valign="middle" >43 (42.2)</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" >≥7</td><td align="center" valign="middle" >9 (15.3)</td><td align="center" valign="middle" ></td></tr></tbody></table></table-wrap><table-wrap id="table6" ><label><xref ref-type="table" rid="table6">Table 6</xref></label><caption><title> Prognostic factors of AHF in the ICU of the UH Pt G</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="2"  >Factors</th><th align="center" valign="middle"  rowspan="2"  >ddl</th><th align="center" valign="middle"  rowspan="2"  >p</th><th align="center" valign="middle"  rowspan="2"  >OR</th><th align="center" valign="middle"  colspan="2"  >95% CI for OR</th></tr></thead><tr><td align="center" valign="middle" >Inf</td><td align="center" valign="middle" >Sup</td></tr><tr><td align="center" valign="middle" >Hypertension (reference)</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >0.039</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Normotension</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0.869</td><td align="center" valign="middle" >1.076</td><td align="center" valign="middle" >0.451</td><td align="center" valign="middle" >2.567</td></tr><tr><td align="center" valign="middle" >Hypotension/collapsus</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0.016</td><td align="center" valign="middle" >4.453</td><td align="center" valign="middle" >1.322</td><td align="center" valign="middle" >14.996</td></tr><tr><td align="center" valign="middle" >Medical history of heart failure</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0.424</td><td align="center" valign="middle" >0.645</td><td align="center" valign="middle" >0.220</td><td align="center" valign="middle" >1.888</td></tr><tr><td align="center" valign="middle" >Hospital stay</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0.001</td><td align="center" valign="middle" >0.181</td><td align="center" valign="middle" >0.067</td><td align="center" valign="middle" >0.486</td></tr><tr><td align="center" valign="middle" >No complications (reference)</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >0.007</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Other complications</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0.134</td><td align="center" valign="middle" >0.387</td><td align="center" valign="middle" >0.111</td><td align="center" valign="middle" >1.342</td></tr><tr><td align="center" valign="middle" >Cardiogenic schock</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0.062</td><td align="center" valign="middle" >10.396</td><td align="center" valign="middle" >0.891</td><td align="center" valign="middle" >121.295</td></tr></tbody></table></table-wrap></sec><sec id="s4"><title>4. Discussion</title><sec id="s4_1"><title>4.1. Age</title><p>The mean age in our study was 58.73 &#177; 18.407, less than the 69.9 &#177; 12.5 of the EHF-II [<xref ref-type="bibr" rid="scirp.90235-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.90235-ref7">7</xref>] study and the 72 &#177; 14.1 of ADHERE [<xref ref-type="bibr" rid="scirp.90235-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.90235-ref8">8</xref>] . This could be explained by the fact that the African population is much younger than the European and American population. However, we found higher mean age compared to DAMASCENO (52.3 &#177; 18.3) [<xref ref-type="bibr" rid="scirp.90235-ref9">9</xref>] . This difference could be explained by the small size of our sample.</p></sec><sec id="s4_2"><title>4.2. Sex</title><p>In our serie, females predominated with 53.1% in agreement with Damasceno [<xref ref-type="bibr" rid="scirp.90235-ref9">9</xref>] , prasart [<xref ref-type="bibr" rid="scirp.90235-ref10">10</xref>] and the adhere study [<xref ref-type="bibr" rid="scirp.90235-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.90235-ref7">7</xref>] [<xref ref-type="bibr" rid="scirp.90235-ref8">8</xref>] with respectively 52%, 50.8% and 50.4%. in contrary there were less female as reported by the EHFS-II study [<xref ref-type="bibr" rid="scirp.90235-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.90235-ref7">7</xref>] where women accounted for only 39%, possibly related to the post-surgical nature of this study.</p></sec><sec id="s4_3"><title>4.3. Past Medical History and Cardiovascular Risk Factors</title><p>Only 16.7% of our patients had already heart failure compared to 66.5% for prasart [<xref ref-type="bibr" rid="scirp.90235-ref10">10</xref>] , 75% for dimitrios [<xref ref-type="bibr" rid="scirp.90235-ref7">7</xref>] and 63% for Nieminen [<xref ref-type="bibr" rid="scirp.90235-ref5">5</xref>] . This could be explained by the difference in level of health education of the population on the one hand and the performance of health systems in these countries on the other.</p><p>Hypertension with 67.4% was the most cardiovascular risk factor found in our study as reported in the literature [<xref ref-type="bibr" rid="scirp.90235-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.90235-ref7">7</xref>] [<xref ref-type="bibr" rid="scirp.90235-ref8">8</xref>] [<xref ref-type="bibr" rid="scirp.90235-ref9">9</xref>] [<xref ref-type="bibr" rid="scirp.90235-ref10">10</xref>] .</p></sec><sec id="s4_4"><title>4.4. Etiology</title><p>As found in the literature [<xref ref-type="bibr" rid="scirp.90235-ref6">6</xref>] - [<xref ref-type="bibr" rid="scirp.90235-ref12">12</xref>] , coronary syndrome and arterial hypertension were the leading causes of AHF with respectively 41.5% and 17.3%.</p></sec><sec id="s4_5"><title>4.5. Evolution and In-Hospital Mortality</title><p>In our serie, the in-hospital mortality of 32.1% was significantly higher than that found in the literature [<xref ref-type="bibr" rid="scirp.90235-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.90235-ref7">7</xref>] [<xref ref-type="bibr" rid="scirp.90235-ref8">8</xref>] [<xref ref-type="bibr" rid="scirp.90235-ref10">10</xref>] [<xref ref-type="bibr" rid="scirp.90235-ref11">11</xref>] [<xref ref-type="bibr" rid="scirp.90235-ref12">12</xref>] [<xref ref-type="bibr" rid="scirp.90235-ref13">13</xref>] , due in part to a situation with less equipment/less financial resources also for patients leading to long delay before starting management.</p></sec><sec id="s4_6"><title>4.6. Factors of Poor Prognostic</title><p>Many factors have been identified as prognostic factors such: BUN (cutoff value of 43 mg/dl), systolic blood pressure (cutoff value of 115 mmHg and serum creatinine (cutoff value of 2.75 mg/dl) in ADHERE registry [<xref ref-type="bibr" rid="scirp.90235-ref14">14</xref>] or patient age, systolic blood pressure, respiratory rate, serum sodium, hemoglobin, BUN and medical history of cerebrovascular disease, dementia, liver cirrhosis or cancer [<xref ref-type="bibr" rid="scirp.90235-ref15">15</xref>] .</p><p>In bivariate analysis, we were able to identify factors with high mortality/poor prognostic: a past history of heart failure, GHF, collapse or hypotension at admission, severely impaired left ventricular ejection fraction and finally, the occurrence during the hospitalization of a cardiogenic shock.</p><p>After logistic regression, only collapse/hypotension at admission was the independent factor of poor prognostic with p = 0.016 and OR = 4.453 (1.322 - 14.996).</p></sec><sec id="s4_7"><title>4.7. Limits of the Study</title><p>Main limit was the availability of echocardiography for all patients. We further were not able to check all patients for labor data such as Pro-BNP, then we know from the literature that there are some biological marker for prognotic. Despite these limits our study provides valueble informations about AHF in a ressource limited environment.</p></sec></sec><sec id="s5"><title>5. Conclusion</title><p>AHF is a common manifestation of heart failure that can be rapidly fatal. The clinical manifestation is noisy but quickly resolute under the adapted treatment. Identifying poor prognostic factors like collapse/hypotension in our study is essential to reduce mortality.</p></sec><sec id="s6"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest regarding the publication of this paper.</p></sec><sec id="s7"><title>Cite this paper</title><p>Youssouf, C., Oumar, B.H., Ibrahima, S., Karamba, T., Souleymane, C., Karim, S.A., Alfousseyni, C., Nouhoum, D., Samba, S., Adama, D., Ichaka, M., Bella, D.I. and Abdoulaye, D.B. (2019) Prognostic Factors for Acute Heart Failure (AHF) in the Cardiology Intensive Care Unit (ICU) of the University Hospital Point G (UH Pt G). World Journal of Cardiovascular Diseases, 9, 42-50. https://doi.org/10.4236/wjcd.2019.91005</p></sec></body><back><ref-list><title>References</title><ref id="scirp.90235-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Ponikowski, P., Voors, A.A., Anker, S.D., et al. (2016) ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure. European Heart Journal, 37, 2129-2200. https://doi.org/10.1093/eurheartj/ehw128</mixed-citation></ref><ref id="scirp.90235-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Ziaeian, B., Sharma, P.P., et al. (2015) Factors Associated with Heart Rate Changes in the United States. American Heart Journal, 169, 282-289.  
https://doi.org/10.1016/j.ahj.2014.11.007</mixed-citation></ref><ref id="scirp.90235-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Shiraishi, Y., Kohsaka, A., Abe, T., et al. (2014) Validation of the Patient with the Guideline Heart Failure Risk in Japanese Patients and the Potential for Improvement of Its Discrimination by the Inclusion of B-Type Natriuretic Peptide Level. Heart, 100, 115-125.</mixed-citation></ref><ref id="scirp.90235-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">National Institute for Health and Care Excellence (2014) Acute Heart Failure: Diagnosing and Managing. Heart Failure in Adults (Clinical Guideline CG187).  
https://www.nice.org.uk/guidance/cg187</mixed-citation></ref><ref id="scirp.90235-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Nieminen, M.S., Brutsaert, D., Dickstein, K., et al. (2006) EuroHeart Failure Survey II (EHFS II): A Survey on Hospitalized Acute Heart Failure Patients: Description of Population. European Heart Journal, 27, 2725-2736.  
https://doi.org/10.1093/eurheartj/ehl193</mixed-citation></ref><ref id="scirp.90235-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Callender, T., Woodward, M., Roth, G., Farzadfar, F., Lemarie, J.-C., et al. (2014) Heart Failure Care in Low- and Middle-Income Countries: A Systematic Review and Meta-Analysis. PLoS Medicine, 11, e1001699.</mixed-citation></ref><ref id="scirp.90235-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Farmakis, D., Parissis, J., Lekakis, J. and Filippatos, G. (2015) Acute Heart Failure: Epidemiology, Risk Factors, and Prevention. Revista Espanola de Cardiología, 68, 245-248. https://doi.org/10.1016/j.recesp.2014.11.009</mixed-citation></ref><ref id="scirp.90235-ref8"><label>8</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Adams</surname><given-names> K.F.</given-names></name>,<name name-style="western"><surname> Fonarow</surname><given-names> G.C.</given-names></name>,<name name-style="western"><surname> Emerman</surname><given-names> C.L.</given-names></name>,<name name-style="western"><surname> LeJemtel</surname><given-names> T.H.</given-names></name>,<name name-style="western"><surname> Costanzo</surname><given-names> M.R.</given-names></name>,<name name-style="western"><surname> Abraham</surname><given-names> W.T.</given-names></name>,<name name-style="western"><surname> et al.</surname><given-names> ADHERE Scientific Advisory Committee and Investigators </given-names></name>,<etal>et al</etal>. (<year>2005</year>)<article-title>Characteristics and Outcomes of Patients Hospitalized for Heart Failure in the United States: Rationale, Design, and Preliminary Observations from the First 100,000 Cases in the Acute Decompensated Heart Failure National Registry (ADHERE)</article-title><source> American Heart Journal</source><volume> 149</volume>,<fpage> 209</fpage>-<lpage>216</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.90235-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Damasceno, A., Mayosi, B.M., et al. (2012) The Causes, Treatment, and Outcome of Acute Heart Failure in 1006 Africans From 9 Countries. Archives of Internal Medicine, 172, 1386-1394. https://doi.org/10.1001/archinternmed.2012.3310</mixed-citation></ref><ref id="scirp.90235-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Laothavorn, P., Hengrussamee, K. and Kanjanavanit, R. (2010) Thai Acute Decompensated Heart Failure Registry (Thai ADHERE). CVD Prevention and Control, 5, 89-95. https://doi.org/10.1016/j.cvdpc.2010.06.001</mixed-citation></ref><ref id="scirp.90235-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Farmakis, D., Parissis, J., Lekakis, J. and Filippatos, G. (2015) Acute Heart Failure: Epidemiology, Risk Factors, and Prevention. Revista Espanola de Cardiología, 68, 245-248. https://doi.org/10.1016/j.recesp.2014.11.009</mixed-citation></ref><ref id="scirp.90235-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Dang, D., Delmas, C., Espinasseau, G., Huo Yung Kai, S., Milhau-Bacharach, S., Beddok, R. and Elbaz, M. (2016) Epidemiology of Acute Cardiac Failure in Cahors (ICAhors) with Analysis of Predictive Factors for a New Hospitalization in the Year for Acute Heart Failure. Annals of Cardiology and Angiology, 65, 375-381.</mixed-citation></ref><ref id="scirp.90235-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Ray, P., Bennaceur, M., Zhao, Y. and Riou, B. (2004) Acute Heart Failure (ICA) of the Elderly Subject in Emergencies. European Journal of Emergencies, 17, 128-131.</mixed-citation></ref><ref id="scirp.90235-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Fonarow, G.C., Adams, K.F., Abraham, W.T., et al. (2005) Risk Stratification for In-Hospital Mortality in Acutcly Decompcnsated Heart Failure Classification and Regression Tree Analysis. JAMA, 293, 572-580.  
https://doi.org/10.1001/jama.293.5.572</mixed-citation></ref><ref id="scirp.90235-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Lee, D.S., Austin, P.C., Rouleau, J.L., et al. (2003) Predictlng Mortality among Patients Hospitalized for Heart Failure: Derivation and Validation of a Clinical Model. JAMA, 290, 2581-2587. https://doi.org/10.1001/jama.290.19.2581</mixed-citation></ref></ref-list></back></article>